Concepedia

Author

Takeshi Nakabayashi

Kissei Pharmaceutical (Japan)

Also Known As

Nakabayashi, Takeshi, T Nakabayashi, Takeshi Nakabayashi

16

Publications

362

Citations

8

H-Index

26

Concepts

All Affiliations

Kissei Pharmaceutical (Japan)Tohoku Medical and Pharmaceutical UniversityTokyo University of Science
TN

About

Takeshi Nakabayashi is an author at Kissei Pharmaceutical (Japan) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

321

2

Biochemistry

3

3

46

3

Natural Sciences

2

2

27

4

Health Sciences

1

1

29

5

Allergy

1

1

53

Takeshi Nakabayashi

×

8

Publications

349

Citations

8

H-Index

YearCitations

Screening of various plant extracts used in ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV‐1) protease

Ines Tomoco Kusumoto, Takeshi Nakabayashi, Hiroaki Kida,

Phytotherapy Research

1995

193

Inhibitory effects of various ayurvedic and Panamanian medicinal plants on the infection of herpes simplex virus‐1 <i>in vitro</i> and <i>in vivo</i>

Masao Hattori, Takeshi Nakabayashi, Yasmina Aura Lim,

Phytotherapy Research

1995

53

Vitamin A toxicity secondary to excessive intake of yellow-green vegetables, liver and laver

Kazuki Nagai, Hiroo Hosaka, Shuichi Kubo,

Journal of Hepatology

1999

29

Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Nobuhiko Fushimi, Hideki Fujikura, Hiroaki Shiohara,

Bioorganic & Medicinal Chemistry

2012

19

A human immunodeficiency virus protease inhibitory substance from <i>Swietenia mahagoni</i>

Ines Tomoco MATSUSE, Takeshi Nakabayashi, Yasmina Aura Lim,

Phytotherapy Research

1997

18

Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Nobuhiko Fushimi, Hirotaka Teranishi, Kazuo Shimizu,

Bioorganic & Medicinal Chemistry

2012

15

Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor

Kazuo Shimizu, Hideki Fujikura, Nobuhiko Fushimi,

Bioorganic & Medicinal Chemistry

2021

12

Functional Characterization of Single Nucleotide Polymorphisms with Amino Acid Substitution in CYP1A2, CYP2A6, and CYP2B6 Found in the Japanese Population

M. Iwasaki, Yoshinobu Yoshimura, Satoru Asahi,

Drug Metabolism and Pharmacokinetics

2004

10

Page 1